Image may be NSFW.
Clik here to view.
Clik here to view.
Isotechnika’s NICAMs demonstrate anti-viral activity
Isotechnika Pharma (TSX: ISA) announced positive results from the first round of screening of its portfolio of cyclophilin antagonist molecules (NICAMs) through the contract testing laboratories of the...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Isotechnika gets more funding for NICAM program
Isotechnika Pharma (TSX: ISA) has received additional funding from the National Research Council Industrial Research Assistance Program (NRC-IRAP) for its non-immunosuppressive cyclophilin antagonist...
View Article
More Pages to Explore .....
